Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Immunol ; 194(12): 6123-32, 2015 Jun 15.
Article in English | MEDLINE | ID: mdl-25957169

ABSTRACT

Mycoplasma pneumoniae is an extracellular pathogen that colonizes mucosal surfaces of the respiratory tract and is associated with asthma exacerbations. Previous reports demonstrate that surfactant protein-A (SP-A) binds live M. pneumoniae and mycoplasma membrane fractions (MMF) with high affinity. Humans express a repertoire of single-amino acid genetic variants of SP-A that may be associated with lung disease, and our findings demonstrate that allelic differences in SP-A2 (Gln223Lys) affect the binding to MMF. We show that SP-A(-/-) mice are more susceptible to MMF exposure and have significant increases in mucin production and neutrophil recruitment. Novel humanized SP-A2-transgenic mice harboring the hSP-A2 223K allele exhibit reduced neutrophil influx and mucin production in the lungs when challenged with MMF compared with SP-A(-/-) mice. Conversely, mice expressing hSP-A2 223Q have increased neutrophil influx and mucin production that are similar to SP-A(-/-) mice. Using tracheal epithelial cell cultures, we show that enhanced mucin production to MMF occurs in the absence of SP-A and is not dependent upon neutrophil recruitment. Increased phosphorylation of the epidermal growth factor receptor (EGFR) was evident in the lungs of MMF-challenged mice when SP-A was absent. Pharmacologic inhibition of EGFR prior to MMF challenge dramatically reduced mucin production in SP-A(-/-) mice. These findings suggest a protective role for SP-A in limiting MMF-stimulated mucin production that occurs through interference with EGFR-mediated signaling. SP-A interaction with the EGFR signaling pathway appears to occur in an allele-specific manner that may have important implications for SP-A polymorphisms in human diseases.


Subject(s)
Genetic Variation , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Mycoplasma pneumoniae/immunology , Mycoplasma pneumoniae/metabolism , Pneumonia, Mycoplasma/genetics , Pneumonia, Mycoplasma/immunology , Pulmonary Surfactant-Associated Protein A/genetics , Animals , Cell Membrane/immunology , Cell Membrane/metabolism , Chemotaxis/immunology , ErbB Receptors/metabolism , Female , Gene Expression , Gene Order , Gene Targeting , Genetic Vectors/genetics , Humans , Lung/immunology , Lung/metabolism , Lung/microbiology , Lung/pathology , Male , Mice , Mice, Knockout , Mice, Transgenic , Mucin 5AC/genetics , Mucin 5AC/metabolism , Mucus/metabolism , Neutrophils/immunology , Neutrophils/metabolism , Phosphorylation , Pneumonia, Mycoplasma/metabolism , Protein Binding , Pulmonary Surfactant-Associated Protein A/metabolism
3.
J Allergy Clin Immunol ; 130(1): 205-14.e2, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22502799

ABSTRACT

BACKGROUND: Mycoplasma pneumoniae (Mp) frequently colonizes the airways of patients with chronic asthma and likely contributes to asthma exacerbations. We previously reported that mice lacking surfactant protein A (SP-A) have increased airway hyperresponsiveness (AHR) during M pneumoniae infection versus wild-type mice mediated by TNF-α. Mast cells (MCs) have been implicated in AHR in asthma models and produce and respond to TNF-α. OBJECTIVE: Determine the contribution of MC/TNF interactions to AHR in airways lacking functional SP-A during Mp infection. METHODS: Bronchoalveolar lavage fluid was collected from healthy and asthmatic subjects to examine TNF-α levels and M pneumoniae positivity. To determine how SP-A interactions with MCs regulate airway homeostasis, we generated mice lacking both SP-A and MCs (SP-A(-/-)Kit(W-sh/W-sh)) and infected them with M pneumoniae. RESULTS: Our findings indicate that high TNF-α levels correlate with M pneumoniae positivity in human asthmatic patients and that human SP-A inhibits M pneumoniae-stimulated transcription and release of TNF-α by MCs, implicating a protective role for SP-A. MC numbers increase in M pneumoniae-infected lungs, and airway reactivity is dramatically attenuated when MCs are absent. Using SP-A(-/-)Kit(W-sh/W-sh) mice engrafted with TNF-α(-/-) or TNF receptor (TNF-R)(-/-) MCs, we found that TNF-α activation of MCs through the TNF-R, but not MC-derived TNF-α, leads to augmented AHR during M pneumoniae infection when SP-A is absent. Additionally, M pneumoniae-infected SP-A(-/-)Kit(W-sh/W-sh) mice engrafted with TNF-α(-/-) or TNF-R(-/-) MCs have decreased mucus production compared with that seen in mice engrafted with wild-type MCs, whereas burden was unaffected. CONCLUSION: Our data highlight a previously unappreciated but vital role for MCs as secondary responders to TNF-α during the host response to pathogen infection.


Subject(s)
Mast Cells/metabolism , Mycoplasma pneumoniae/pathogenicity , Pneumonia, Mycoplasma/immunology , Pulmonary Surfactant-Associated Protein A/deficiency , Receptors, Tumor Necrosis Factor/metabolism , Animals , Asthma/immunology , Asthma/metabolism , Bronchial Hyperreactivity/immunology , Bronchial Hyperreactivity/metabolism , Bronchoalveolar Lavage Fluid , Cells, Cultured , Humans , Lung/metabolism , Mast Cells/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mycoplasma pneumoniae/immunology , Pneumonia, Mycoplasma/physiopathology , Pulmonary Surfactant-Associated Protein A/genetics , Receptors, Tumor Necrosis Factor/genetics , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...